In mammals, GRF and pituitary adenylate cyclase-activating polypeptide (PACAP) are encoded in separate genes. We report here that in the salmon a 4.5-kilobase gene contains five exons that encode the biologically active part of the GRF-like peptide (amino acids 1-32) on exon 4 and PACAP on exon 5. Analysis of two fish messenger RNAs reveals that a long precursor containing GRF and PACAP and a short precursor containing only PACAP are both expressed in the brain of at least five species of salmon, whereas mice express only the long precursor encoded by the PACAP gene. Synthetic salmon PACAP-38 and salmon GRF-like peptide-45 both stimulated GH release from cultured salmon pituitary cells; PACAP stimulated a concentrationdependent release of GH at both 4 and 24 h of incubation, whereas GRF-like peptide did not. Alternative splicing, resulting in the short precursor in which GRF-32 is excised, may provide a means for differential control of GH secretion with higher production of the more potent PACAP. A duplication of the GRF-like/PACAP gene in evolution after the divergence of fish and tetrapods would explain separate genes and regulation for GRF and PACAP in mammals. (Endocrinology 138: 414 -423, 1997) 
T HE IDENTITY of GRF in vertebrates other than mammals has remained controversial, even though the primary structure of GRF for humans has been known since 1982. GRF was isolated from human pancreatic tumors (1, 2) and human infundibula (3) based on a bioassay for the release of GH from cultured rat pituitary cells. At present, GRF has been isolated and sequenced from brain tissue (4 -9) or deduced from complementary DNA (cDNA) sequences (10 -15) for eight mammalian species. The GRF gene has been reported only for the human and rat (12, 16) . The GRF peptides are not highly conserved in structure. Mouse GRF, for example, compared with human (h) GRF has only 61% sequence identity, is not amidated, and is two amino acids shorter. This structural variability may explain why a molecule with structural similarity to GRF has never been reported for birds, reptiles, or amphibians.
More recently, a neuropeptide named pituitary adenylate cyclase-activating polypeptide (PACAP) was reported to release GH in mammals (17, 18) . This peptide is encoded on a separate gene from GRF in mammals (19) . In addition, there is another peptide that has structural similarity to GRF and is encoded in the PACAP gene. This molecule, named PACAP-associated peptide (PRP), has no known function to date (20) . PACAP and PRP are structurally related to GRF, and all three peptides are members of a superfamily of peptides that includes glucagon, vasoactive intestinal peptide (VIP), peptide histidine-methionine, glucose-dependent insulin-inducing peptide (GIP), and secretin.
In 1992 a GRF-like peptide isolated from carp brains was found to have structural similarity with mammalian GRF peptides and to stimulate GH release (21) . We reported that a cDNA isolated from salmon brain encoded two peptides in the same precursor (22) . One of these peptides is related to the carp GRF, mammalian PRP, and mammalian GRF. The other peptide is PACAP, which has a sequence identity of 92% to amphibian (23) and mammalian PACAP (17) .
It is clear from these studies that structural analysis of the fish gene and physiological studies of the encoded peptides are needed to determine whether the regulation of growth in fish is distinct from that in mammals. We identify the salmon (s) GRF-like/PACAP gene and its tissue distribution and examine whether the two peptides encoded in this gene have a role in the central control of growth in fish. Exon skipping in the fish gene is considered a mechanism to express the more potent of the GH-releasing peptides. We also consider whether the encoding of GRF and PACAP in a single gene in fish implies a coordinated function that should be considered in mammals, although the two neuropeptides are coded in separate genes.
Materials and Methods

Screening of sockeye salmon genomic library
A sockeye salmon genomic library in Fix II (Stratagene, La Jolla, CA), provided by Dr. R. Devlin, was screened with an 135-bp sockeye salmon cDNA probe labeled with [ 32 P]deoxy-CTP (DuPont, Wilmington, DE). This probe, amplified by PCR with primers CSC33 (5Ј-CA[CT]-GCIGA[CT]GGIATGTT[CT]AA-3Ј) and NMS 1 (5Ј-TGACAGAG-GCTCTGTGTC-3Ј), contained the entire coding sequence of the GRFlike region from positions 243-378 as described by Parker et al. (22) . Filters were washed four times for 5 min each time at room temperature in 2 ϫ SSC (standard saline citrate)-0.1% SDS, twice at 55 C for 20 min each time in 1 ϫ SSC-0.1% SDS, and then for 20 min at 55 C in 0.2 ϫ SSC-0.1% SDS. Before rescreening the first round of positive clones, 10 l DNA lysate from each clone were amplified using PCR with 40 pmol of the primers CSC33 and NMS1. PCR was performed with 50 mm KCl, 10 mm Tris-HCl, 0.1% Triton X-100, 1.5 mm MgCl 2 , 200 m deoxy-NTPs, and 2.5 U Taq DNA polymerase (Promega, Madison, WI). DNA was amplified using a step program of 1 cycle at 94 C for 3 min, 50 C for 2 min, and 72 C for 5 min, followed by 36 cycles of 94 C for 1 min, 50 C for 1 min, and 72 C for 1 min 30 sec (Perkin-Elmer/Cetus, Norwalk, CT). The last cycle had a final extension of 5 min at 72 C. PCR-positive lysates were rescreened to obtain single isolated plaques. Hybridization and washing stringencies were increased in subsequent screenings, with a final wash at 60 C in 0.1 ϫ SSC-0.1% SDS.
Subcloning and sequencing
GRF/PACAP clones were digested with the restriction enzymes HaeIII, SacI, AccI, and XbaI, and the fragments were subcloned into pBluescript KS ϩ II by blunt end ligation as previously described (22) . Plasmid DNA for exonuclease III (ExoIII) digestion was prepared using Qiagen Plasmid Preps (Qiagen Corp., Chatsworth, CA). ExoIII deletions and S1 nuclease digestions were performed in accordance with the Promega Erase-a-Base System (Protocols and Applications Guide, Promega Corp.). Double stranded DNA sequencing was carried out using the dideoxy chain termination method with Sequenase version 2.0 (U.S. Biochemical Corp., Cleveland, OH) or by thermocycle sequencing with vent (exo-) DNA polymerase (Circumvent, New England Biolabs, Beverly, MA) according to the manufacturer's instructions. Sequencing products were run on 5% polyacrylamide in 7 m urea wedge and normal gels (Bio-Rad Laboratories, Richmond, CA). Gels were dried under vacuum at 80 C and then exposed to XAR-5 film (Eastman Kodak, Rochester, NY) for 16 -24 h. Sequence-specific primers were synthesized at the Regional DNA Synthesis Laboratory, University of Calgary (Calgary, Canada), or at the HSC/Biotechnology Center (Toronto, Canada). M13 universal and reverse primers were obtained from Stratagene.
Primer extension
Primer extension analysis was performed as previously described (24) with modifications. A 30-bp primer (5Ј-TCGCCCCCATCCTCTCG-GAATGTAACACTG-3Ј) was end labeled with 200 Ci [ 32 P]ATP in 1ϫ One-Phor-All Buffer PLUS (Pharmacia, Piscataway, NJ) with 9.2 U T 4 PNK. The reaction mixture was incubated at 37 C for 40 min, followed by heat denaturation of the enzyme at 65 C for 5 min. Labeled primer (2.5 ng, 10 6 cpm) was ethanol precipitated with 20 g sockeye salmon messenger RNA (mRNA) overnight at Ϫ20 C. The mRNA-primer mix was dissolved in 10 l diethylpyrocarbonate-treated water plus 4 l 5 ϫ BRL first strand buffer [250 mm Tris-HCl (pH 8.3), 375 mm KCl, and 15 mm MgCl 2 ] and heated for 5 min at 85 C, followed by a 10-min incubation at 50 C. RNA guard (Pharmacia) was added, and the mixture was incubated for 4.5 h at 50 C. Reverse transcription (RT) was performed at 42 C for 1 h with the addition of dithiothreitol to 10 mm, dNTPs to 0.5 mm, and 200 U SuperScript ribonuclease H Ϫ reverse transcriptase (Life Technologies, Rockville, MD). The sample was phenol/chloroform extracted and precipitated with 2.5 mm ammonium acetate and 2.5 vol ethanol. DNA was dissolved in TE buffer (10 mm Tris⅐Cl, 1 mm EDTA), pH 8.0, and running buffer (New England Biolabs, Beverly, MA), and a sample was run on 5% polyacrylamide-urea gel.
RT-PCR isolation of GRF/PACAP from salmon species and tissues
Sockeye salmon [Oncorhynchus nerka (O. nerka)], coho salmon (O. kisutch), chinook salmon (O. tshawytscha), rainbow trout (O. mykiss), and Atlantic salmon (Salmo salar) were killed by decapitation, and the brains were immediately excised and frozen in liquid nitrogen. Heart, intestine, liver, and pyloric cecum/pancreas from sockeye salmon were also recovered and rapidly frozen. RNA was isolated by the guanidium isothiocyanate method of Chomczynski and Sacchi (25) . Polyadenylated [poly (A) ϩ ] mRNA was isolated by means of oligo(deoxythymidine)-cellulose using the FastTrack mRNA kit (Invitrogen, San Diego, CA). Single stranded cDNA was synthesized from 1 g mRNA by random priming with oligo(deoxythymidine) 18 -20 (Pharmacia) . The cDNA was diluted 1:10, and 1 l was used as the template in PCRs. The primers NMS10 (5Ј-AATGCAGATCTCTCCACACGGTAATAGCAGG-3Ј) and NMS5 (5Ј-AGTCACCTAGCGAGAACACAAG-3Ј) were synthesized to correspond to the 5Ј-and 3Ј-untranslated regions of the sockeye sGRF/ PACAP cDNA sequence, respectively (22) . DNA was amplified in 1 ϫ Promega buffer as described above, using a program of 5 cycles of 94 C for 2 min, 58 C for 2 min, and 72 C for 2 min, followed by 30 cycles of 94 C for 1 min, 57 C for 1.5 min, and 72 C for 1.5 min.
PCR products were separated on 1.5% agarose gels, the bands were excised, and the DNA was recovered by centrifugation through ProSpin columns (Millipore Corp., Bedford, MA). The eluted DNA was phenol/ chloroform extracted, then ethanol precipitated and ligated into pGEM Vector-T plasmid (Promega). Plasmids were electroporated into Escherichia coli JM109 cells using a Bio-Rad Gene Pulser following the manufacturer's instructions. Colonies were picked by blue and white selection, and the bacteria were grown overnight at 37 C. Plasmid DNA was isolated using a Wizard Miniprep kit (Promega), and the inserts were sequenced.
RT-PCR products of the various sockeye tissues were recovered as described above and sequenced directly using the Circumvent Thermocyle Sequencing kit (New England Biolabs) with primers NMS5 and NMS10.
RT-PCR isolation of PRP/PACAP from mouse brain
The brains were removed from two mice that had been killed with CO 2 . The brains were frozen in liquid N 2 . Poly(A) ϩ and cDNA were prepared from the brain as described for the salmon tissues. Primers PA1 (5Ј-ATGACCATGTGTAGCGGAGCAAGGTTGGC-3Ј) and PA2 (5Ј-CGCTACAAGTACGCTATTCGGCGTCC-3Ј) were synthesized corresponding to the 5Ј-end of the signal peptide and the 3Ј-end of PACAP of the rat PACAP gene (26) . PCR was performed as described above, except that a program of 35 cycles of 94 C for 1.5 min, 56 C for 1.5 min, and 72 C for 1.5 min was used. The PCR products were vector T cloned and partially sequenced to confirm the identity of the band.
Peptide synthesis
Sockeye sGRF (His-Ala-Asp-Gly-Met-Phe-Asn-Lys-Ala-Tyr-ArgLys-Ala-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Tyr-Leu-His-Ser-Leu-MetAla-Lys-Arg-Val-Gly-Gly-Gly-Ser-Thr-Met-Glu-Asp-Asp-Thr-Glu-ProLeu-Ser-OH) and sockeye sPACAP (His-Ser-Asp-Gly-Ile-Phe-Thr-AspSer-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-AlaAla-Val-Leu-Gly-Lys-Arg-Tyr-Arg-Gln-Arg-Tyr-Arg-Asn-Lys-NH 2 ) were synthesized using standard solid phase methodologies on a chloromethyl (2 g) and a paramethylbenzhydrylamine (2 g) resin to yield the peptide-free acid (GRF) and the amide (PACAP), respectively. The tertiobutyloxycarbonyl strategy with trifluoroacetic acid deblocking and final hydrofluoric acid cleavage and deprotection was used (27, 28) . Purification using preparative reverse phase HPLC and several eluting solvent systems yielded highly purified peptides (29) (yield for GRF, 62 mg; yield for PACAP, 176 mg). Purified peptides were characterized by amino acid analysis giving the expected ratios, capillary zone electrophoresis (GRF Ͼ95% pure, PACAP Ͼ70% pure), and liquid secondary ion mass spectrometry (monoisotopic mass for GRF: calculated, 4937.46; found, 4937.5; average mass for PACAP: calculated, 4655.41; found, 4654.9).
In vitro pituitary cell assays
For each experiment, 8 -12 coho salmon (200 -300 g) were anesthetized in MS 222 and decapitated, and the pituitaries were removed and placed in modified Hanks' Balanced Salt Solution (HBSS; 136.9 mm NaCl, 5.4 mm KCl, 0.8 mm MgSO 4 , 0.3 mm Na 2 HPO, 8.0 mm NaHCO 3 , 1.26 mm CaCl 2 , 2.0 mm glucose, 10 mm HEPES, and phenol red) on ice. Pituitaries were washed once in HBSS containing 5-fold concentrated antibiotics, then three times in HBSS containing 1-fold concentrated antibiotics. After removal of the HBSS wash, several drops of 0.1% trypsin (1:250; Life Technologies, Grand Island, NY) in HBSS containing 0.3% BSA were added. The pituitaries were minced to approximately 0.1 mm using a sterile razor blade and subsequently transferred to a flask for trypsinization. Pituitary tissue was stirred gently for 30 min at 15 C in air, and centrifuged at 200 ϫ g to pellet the cells. The cells were suspended in 10 ml trypsin inhibitor (25 mg/ml HBSS and 0.3% BSA) and incubated for 5 min at 15 C with gentle shaking. The cells were centrifuged and suspended in 10 ml deoxyribonuclease II (100 g/10 ml HBSS and 0.3% BSA), incubated, and centrifuged as previously described. Pituitary cells were washed once in 10 ml Ca 2ϩ -free HBSS and 2 mm EGTA, once in Ca 2ϩ free HBSS and 1 mm EGTA, and once in Ca 2ϩ -free HBSS, then suspended in 10 ml Ca 2ϩ -free HBSS and filtered through a 100-mesh stainless steel screen. Cell density was determined using a hemocytometer, whereas cell viability was determined by trypan blue staining. Cells were centrifuged and suspended in Waymouth's medium (10 mm HEPES, 8 mm NaHCO 3 , 2 mm glucose, 100 U/ml penicillin G, 100 g/ml streptomycin sulfate, and 10 g/ml gentamycin, pH 7.63) containing 2% UltroSer Sf (Life Technologies). Dispersed pituitary cells were incubated in 96-well culture plates [Falcon 3872 (Becton Dickinson, Oxnard, CA); 250 l/well at 2.5 ϫ 10 5 cells/ml] at 15 C in air for 72 h, then overnight with HBSS.
Peptides were dissolved in HBSS and 0.1% BSA immediately before addition to the cell cultures. The pituitary cells were then incubated with peptide in HBSS and 0.3% BSA for 4 or 24 h. In the assays, ascorbic acid was added to the peptide solution and media to a final concentration of 0.5 mm. Six replicates were used for each peptide concentration. Culture medium was either analyzed immediately or frozen at Ϫ80 C. Medium was analyzed for GH by RIA (30, 31) . The recombinant chum sGH was provided by Kyowa Hakko Kogyo Co. (Tokyo, Japan), whereas the primary antiserum (HU-85) was raised in a rabbit against the recombinant chum sGH and provided by Dr. Akihiko Hara, Hokkaido University (Hakodate, Japan). Data analyses were performed by one-factor ANOVA followed by Fischer's protected least significant difference test for significance at P Ͻ 0.05.
Results
Sequence and organization of salmon gene
Four clones obtained by screening 300,000 plaques from a sockeye salmon genomic library were shown by PCR and sequencing to contain a GRF-like sequence (22) and part of an intron. Two of these four clones were tested and found to be identical when analyzed by restriction enyzme digestion, Southern blotting, and sequencing (data not shown). Only restriction digest fragments of clone PL1 were subcloned. One subclone containing a SacI fragment was completely sequenced for both strands. This subclone spanned 4537 bp and contained the five exons plus 588 bp of 5Ј-flanking and 431 bp of 3Ј-flanking regions (Fig. 1) . Figure 2 shows that exon I encodes the 5Ј-untranslated region. Exon 2 encodes 10 bp of the 5Ј-untranslated region, the signal peptide, and part of the 5Ј-cryptic peptide. The majority of the 5Ј-cryptic peptide is encoded on exon 3. Exon 4 encodes the last 3 amino acids of the cryptic peptide and the first 32 amino acids of the GRF-like peptide. Exon 5 encodes the remaining 13 amino acids of the GRF-like peptide, a dibasic amino acid processing site, PACAP, and the 3Ј-untranslated region.
A comparison of the gene with the two cDNA sequences showed that 16 nucleotides were different; 5 amino acid changes resulted from nucleotide changes within the signal and cryptic peptides. In the GRF coding region, the gene matched one cDNA and encoded identical amino acids to the other cDNA, except in amino acid 41, where Ser or Thr was present (22) ; Thr was selected for the synthetic peptide. In the PACAP-coding region, again the gene matched one cDNA and encoded identical amino acids to the second cDNA except for residue 37, where Ser or Asn was present; Asn was selected for the synthetic peptide.
Transcription initiation site
Analysis of the sGRF-like/PACAP gene by primer extension was used to determine the potential transcription start site(s). Three major extension products from brain were observed corresponding to nucleotides that are 465, 472, and 473 bp upstream of the translation start site (Fig. 3) . Two minor bands were also evident between the major bands. The negative control, which was mRNA prepared from heart tissue, did not result in an extension product (Fig. 3) .
Alternative splicing and tissue expression
Two RT-PCR products from brain cDNA are shown in Figs. 4A and 5A. Sequence analysis shows that the two bands represent long and short precursors encoded in the sGRFlike/PACAP gene (Fig. 6) . The region deleted in the short cDNA precursor corresponds to the excision of exon 4 containing most of the GRF domain of the gene (Figs. 1 and 6 ). This exon codes for the last 3 amino acids of the cryptic peptide and the first 32 amino acids of the GRF-like molecule. The gene structure (Fig. 1) shows exon/intron splice sites at nucleotide positions corresponding to the exon splice sites indicated in Fig. 6 .
Although there were nucleotide substitutions, they resulted in only one amino acid substitution within the GRF-PACAP-coding region of the precursors from the five species; chinook salmon had a leucine in place of phenylalanine at position 84 in the GRF-like region. All other amino acid substitutions are within the signal peptide and cryptic peptide regions (Fig. 6) .
Alternative splicing occurs not only in the brain, but also in other specific tissues (Fig. 4A) . Two bands of the same size as the full-length and short forms of the cDNA precursor were expressed in the pyloric cecum/pancreas and the large and small intestine in 1.5-yr-old fish (Fig. 4A) . We did not find any GRF-like/PACAP mRNA expression in liver, heart (Fig. 4A ), or gonads (not shown) in fish of the same age. Tubulin was consistently amplified in all tissues as a control of mRNA quality (Fig. 4B) .
Tissue expression of mouse brain PACAP cDNA
Only one band resulted from the RT-PCR of mouse brain cDNA with primers that matched the sequence of the rat PACAP cDNA. The sequence of the mouse PCR product was that of the long precursor containing full-length PRP and PACAP (Fig. 5B) . In contrast, analysis of five salmonid species (sockeye salmon, coho salmon, chinook salmon, Atlantic salmon, and rainbow trout) showed that both the long and short cDNA precursors were expressed in the brains of all of these species (Fig. 5A ). Both the long and short bands were sequenced in their entirety for each species. The excision of exon 4 occurred in each species.
In vitro effects of GRF and PACAP on GH release
In all bioassays PACAP stimulated GH release in a concentration-dependent manner (Fig. 7) . PACAP stimulated GH release above control levels at both 4 and 24 h of incubation. Although the levels of GH in the incubation medium were higher at 24 h than at 4 h, the fold stimulations at these two time points were similar (Fig. 7A) . The release of GH by PACAP was significant at a dose as low as 0.1 nm compared to the control value. Ascorbic acid was added in the experiments to prevent oxidation of the peptides because sPACAP has one methionine and sGRF-like peptide has three methionines.
sGRF-like peptide compared with PACAP was more variable in stimulating a significant release of GH. GH release was not concentration dependent with sGRF-like peptide (Fig. 7B) . sGRF-like peptide was effective at 0.001 nm at 4 h, but did not consistently result in a significant release of GH at the higher doses. There was not a significant release of GH at 24 h in response to GRF-like peptide.
It should be noted that synthetic sockeye sGRF and sockeye PACAP are each one amino acid different from the peptides deduced from the gene reported here. Each peptide, however, is identical to those deduced from one of the two cDNAs that we isolated earlier from a sockeye brain library (22) ; the other cDNA and the gene encode identical peptides.
Discussion
The salmon gene encodes two peptides: PACAP and GRFlike peptide
We have identified a sGRF-like/PACAP gene, which is the first complete gene to be identified for the glucagon-VIPsecretin superfamily for any vertebrate other than mammals. Although the salmon gene is a member of the superfamily, this fish gene appears to be distinct compared to the mammalian genes, in which GRF and PACAP are separately encoded.
Structural organization of the GRF-like/PACAP gene was determined by comparison to the two sockeye cDNA sequences previously obtained by Parker et al. (22) . The gene contains five exons; the GRF code spans exons 4 and 5, whereas PACAP is exclusively encoded on exon 5. Structural organization of the salmon gene also shows that it is more closely related to the hPRP/PACAP gene than to the hGRF gene. PACAP and the region reported to be the biologically active core of GRF-like peptide (amino acids 1-32) (32) are encoded on distinct exons of the salmon gene. The presence of active peptides encoded on separate exons is characteristic of members of the glucagon superfamily (33) . The size and sequence identity of the exons encoding peptide domains are well conserved between the salmon and human PACAP genes.
The introns of the sGRF-like/PACAP gene contain the consensus GT/AG splice donor/acceptor sites (34), a pyrimidine-rich region just upstream of the 3Ј-splice site and a branch point recognition sequence, all associated with intron splice recognition. The main difference in the structural organization of the sockeye salmon gene compared to that of the human, is the smaller introns in the former. The sGnRH genes also have smaller introns than their mammalian counterparts (35, 36) . Whether regulatory differences exist in the shorter introns of fish compared to those of mammals is not yet known.
sPACAP is more tightly conserved than sGRF-like peptide
A comparison of the biologically active core of sGRF-like peptide-(1-29) to hPRP-(1-29) shows 59% and that to hGRF-(1-29) shows 55% sequence identity. This suggests that the sGRF-like peptide has structural similarity to both human peptides. However, sGRF-like peptide is closer to hPRP (54%) than GRF (40%) if the full-length (44 -48 amino acids) peptide is considered. A more striking sequence identity was observed for the PACAP molecules. sPACAP has 90% sequence identity with hPACAP-(1-38) and 100% identity with hPACAP- . This implies that a greater functional constraint exists on PACAP than on the GRF-like peptide and may explain the past difficulty in identifying GRF for vertebrates other than mammals.
The potential cleavage sites in the salmon precursor are also conserved. There are dibasic residues that are potential processing sites, the cleavage of which would result in PACAP-38, and GRF-like peptide-45 or their truncated versions of PACAP-27 or GRF-29.
The gene has multiple start sites and polyadenylation sites
To define sequences that may be important for expression of the GRF-like/PACAP gene, we sequenced the 5Ј-flanking region of the gene. The length of the 5Ј-untranslated region is not known for the PACAP cDNA species reported to date, although it is at least 0.5-0.6 kilobases in rat and sheep. In our study of the transcriptional initiation site, we found three major and two minor extension products upstream of the translation start site. The two major bands at nucleotides 472 and 473 upstream from the start site may represent a single initiation site at the adenine; the band at the thymidine may be part of the "cap effect," which is caused by stopping the polymerase 1-2 nucleotides before the capping site. However, the third band, which corresponds to a guanidine, is seven nucleotides downstream from the A and may be a distinct initiation site.
Possible regulatory elements were identified in the 5Ј-flanking region, including a TATA motif that begins 32 nucleotides upstream from the most 5Ј-start site. Consensus sites for activating protein-2 (AP-2), CAAT, and a half-cAMP response element (CRE) are also present. The initiation site was not determined for the hPACAP gene (19) , but the 5Ј-flanking region of the sGRF-like/PACAP gene resembles the human and rat genes for VIP (37, 38) , glucagon (39) , GRF (12, 16) , GIP (40) , and secretin (41) in that they all have a TATA sequence, most have a CAAT sequence, and a few have a full or half-CRE and/or an AP-2 consensus site. Sequence analysis of the 3Ј region of the gene revealed three polyadenylation signals. We had previously only identified a cDNA terminating with a poly(A) tail 16 nucleotides after the first polyadenylation signal. Downstream of the first polyadenylation signal were several (U)TG-rich elements (TTTTTCT, TGTTTT, and TTTGTA), which were reported to be involved in polyadenylation signal recognition and 3Ј-cleavage (42) . These elements overlap and are located between 6 -20 bp downstream from the end of the mRNA cleavage site.
The mRNA is alternatively spliced in several tissues, resulting in greater expression of PACAP
Sequence analysis of the two RT-PCR products from brain cDNA shows that the two bands represent long and short precursors encoded in the sGRF-like/PACAP gene, confirming our earlier suggestion that the short precursor might be obtained by exon skipping during processing of the RNA transcript (22) . The region deleted in the short cDNA precursor corresponds to the excision of exon 4 containing most of the GRF domain of the gene.
Alternative splicing occurs not only in the salmon brain, but also in the pyloric cecum/pancreas and the large and small intestine in 1.5-yr-old fish. In mammals, GRF has been isolated as a peptide or mRNA from brain, testis, ovary, placenta, and pancreatic tumors (43) . PACAP peptide and mRNA have been identified to date from mammalian brain and testis (43) . sGRF-like/PACAP expression is unlike that of mammalian GRF or PACAP, because the fish mRNA is found in normal pyloric cecum/pancreas and intestine. Although we did not find GRF/PACAP mRNA in salmon gonads, the explanation may be that young fish were used. In adult catfish, we found that GRF-like/PACAP was expressed in both ovary and testis as well as in stomach (44). 
Mouse PACAP mRNA is not alternatively spliced in contrast to salmon mRNA in five species
It is interesting that salmon have a short precursor that has not been identified in mammals. To confirm this, we used mouse brain to show that only the long precursor containing full-length PRP and PACAP is expressed. Both the long and short cDNA precursors were expressed in the brain of each of the five salmonid species; in each case, exon 4 was excised in the short precursor.
Alternate splicing of the RNA means that GRF-like peptide and PACAP need not be released in equimolar quantities as expected from cleavage of the long precursor, but that additional quantities of PACAP could be released from the short precursor. The ratio of expression of the long and short precursors can vary in the brains of different salmonid species, as shown in Fig. 5 . However, the physiological relevance of altering the ratio of the two peptides that both release GH may stem from other actions not yet identified for the salmon GRF-like and PACAP peptides.
PACAP is a potent releaser of GH in vitro
Our data suggest that sPACAP, compared with sGRF-like peptide, is the more potent releaser of GH, in that PACAP resulted in a good concentration-release curve and in GH release that was prolonged, as measured at both 4 and 24 h. GRF-like peptide had a lower threshold concentration than PACAP at 4 h, but the GH level was variable and was not significantly elevated at the highest concentration of sGRFlike peptide. Our results agree with studies on carp GRF-like peptide showing that GH is released in vitro from fish pituitary cells. However, in contrast to our studies, carp GRF-like peptide released GH in a concentration-dependent manner from rainbow trout pituitary cells (but only with ascorbic acid) (32) and from goldfish pituitary cells (even without ascorbic acid) (21) . The reason that we did not obtain a concentration-dependent response to sGRF is not thought to be due to a difference between salmon and carp GRF structures, because the peptides are 91% identical. A more likely explanation is that our experiments used a homologous assay in which the peptides and pituitary cells were from the same species. Hence, both studies suggest that at least one physiological function of salmon and carp GRF is to release GH from the pituitary. The possibility cannot be discounted that a more effective sGRF has yet to be found. Meanwhile, the reason for the release of both PACAP and GRF together is not yet clear.
Gene duplication may explain separate PACAP and GRF genes in mammals
At present, only one GRF-like/PACAP gene has been identified in salmon. Our Southern blot analysis suggested that more than one gene or different allelic polymorphisms are present (22) . Because salmon are tetraploid, they contain duplicates of their genes, but not all duplicates have been retained during evolution (45) . Two genes for melanin-con- centrating hormone and two precursors for vasotocin and CRF (46) have been identified in salmon.
The identification of the GRF-like/PACAP gene in a fish provides insight into the evolution of this superfamily of hormones. In mammals, the related structures and similar localization in the brain and gut of GRF, PACAP, VIP, peptide histidine-methionine, glucagon, secretin, and GIP suggest that the peptides evolved due to repeated gene duplications. The tandem arrangement of some of the peptides in precursors implies that exon duplication has occurred. We hypothesize that fish contain a gene encoding both GRF and PACAP, although it is possible that a gene encoding GRF-like peptide separately has yet to be found. Gene duplication in evolution after the fish-tetrapod split may have led to two separate genes in mammals: GRF and PRP/PACAP. Indeed, a function has been identified for neither PRP in the mammalian PACAP genes nor C peptide (or cryptic peptide) encoded in the GRF gene. Hence, the tandem coding in the mammalian genes does not appear to produce a functional peptide after the proposed gene duplication. Regardless of the origin, separate regulation of the GRF and PACAP genes in mammals may provide finer control of the two neuropeptides compared to that in fish.
